Collaborations in 2026

Who’s Partnering with Whom? Orthopedic Collaborations in 2026

These partnerships demonstrate the many ways that companies find strength in numbers throughout the subsegments, creating a stronger industry as a whole.

A quarterly recap of hip product launches

Stryker Gaining Ground in OUS Hip Replacement Market

Our chart of the month looks at the ten-year sales history for OUS hip replacement among Zimmer Biomet, Stryker and DePuy Synthes.

Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.

Takeaways from THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT

Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.

Orthoflash®
Stryker Mako RPS
Full Market Launch of Stryker Mako RPS

Expanding the Mako portfolio beyond robotic-arm assisted surgery, Mako RPS combines robotic execution, intraoperative planning and a familiar handheld power tool workflow.

,
OSSIOfiber interference screw
OSSIO Launches OSSIOfiber Interference Screw

The bio-integrative, metal-free fixation implant delivers metal-like fixation strength while ultimately integrating into the patient’s native bone.

,
SIGNUS USA VertaConnect Expandable Lumbar Fusion Spine Implant
First U.S. Surgery with SIGNUS USA’s VertaConnect

The next-gen TLIF implant is engineered to maximize performance in both traditional open procedures, as well as with endoscopic approaches.

,
AlloSource ReConnes
AlloSource Introduces Reconnex Pre-sutured Tendon

ReConnex is a ready-to-use, FDA 510(k)-cleared device designed to help simplify all-inside anterior cruciate ligament reconstruction.

,
Miach Ortho BEAR Implant
BEAR Implant Registry Data Demonstrate Low ACL Retear Rates

Miach Orthopaedics initiated the Bridge Registry to assess real-world outcomes for the Bridge-Enhanced ACL Restoration (BEAR) Implant.

,
Competitive Landscape
Industry Voices

Contact Us

  • This field is for validation purposes and should be left unchanged.

0